CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians
- PMID: 10221569
- DOI: 10.1002/(sici)1097-0045(19990501)39:2<130::aid-pros8>3.0.co;2-#
CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians
Abstract
Background: CAG repeat length in exon 1 of the androgen receptor (AR) gene correlates inversely with transcriptional transactivation activity of the AR. Men with shorter AR CAG repeat lengths are at higher risk of prostate cancer. Because benign prostatic hyperplasia (BPH) is an androgen-dependent condition, we examined the hypothesis that a shorter AR gene CAG repeat length increases the risk of developing of BPH.
Methods: Among 14,916 men of the Physicians' Health Study who had provided a blood sample in 1982, we measured AR gene CAG repeat lengths for 310 men who had surgery for BPH up to 7.5 years of follow-up and 1,041 controls.
Results: Risk of surgery for BPH increased linearly with decreasing AR CAG repeat length (P (trend) = 0.03). Relative to men with a CAG repeat length > or = 25, men with a repeat length < or = 19 had an odds ratio of BPH surgery of 1.76 (95% confidence interval, 1.16-2.65).
Conclusions: Variability in the AR gene CAG repeat influences the development of symptomatic BPH.
Similar articles
-
The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.Urology. 1999 Jan;53(1):121-5. doi: 10.1016/s0090-4295(98)00468-3. Urology. 1999. PMID: 9886600
-
Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth.Prostate. 1999 Dec 1;41(4):253-7. doi: 10.1002/(sici)1097-0045(19991201)41:4<253::aid-pros5>3.0.co;2-9. Prostate. 1999. PMID: 10544298
-
Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.Malays J Pathol. 2019 Dec;41(3):243-251. Malays J Pathol. 2019. PMID: 31901908
-
[Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].Zhonghua Nan Ke Xue. 2014 Feb;20(2):172-6. Zhonghua Nan Ke Xue. 2014. PMID: 24520673 Chinese.
-
The androgen receptor CAG repeat: a modifier of carcinogenesis?Mol Cell Endocrinol. 2002 Jul 31;193(1-2):109-20. doi: 10.1016/s0303-7207(02)00104-1. Mol Cell Endocrinol. 2002. PMID: 12161010 Review.
Cited by
-
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness.Sci Rep. 2017 Dec 4;7(1):16862. doi: 10.1038/s41598-017-16700-y. Sci Rep. 2017. PMID: 29203868 Free PMC article.
-
Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.Ann Saudi Med. 2004 Jan-Feb;24(1):21-6. doi: 10.5144/0256-4947.2004.21. Ann Saudi Med. 2004. PMID: 15310009 Free PMC article. Clinical Trial.
-
Benign prostatic hyperplasia: from bench to clinic.Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19. Korean J Urol. 2012. PMID: 22468207 Free PMC article.
-
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.Prostate. 2010 May 1;70(6):584-90. doi: 10.1002/pros.21092. Prostate. 2010. PMID: 19938041 Free PMC article.
-
Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.Eur Urol. 2014 Oct;66(4):752-68. doi: 10.1016/j.eururo.2014.01.007. Epub 2014 Jan 22. Eur Urol. 2014. PMID: 24491308 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials